CN1290832C - 作为高选择性的环加氧酶-2抑制剂的1h-吲哚衍生物 - Google Patents
作为高选择性的环加氧酶-2抑制剂的1h-吲哚衍生物 Download PDFInfo
- Publication number
- CN1290832C CN1290832C CNB028200799A CN02820079A CN1290832C CN 1290832 C CN1290832 C CN 1290832C CN B028200799 A CNB028200799 A CN B028200799A CN 02820079 A CN02820079 A CN 02820079A CN 1290832 C CN1290832 C CN 1290832C
- Authority
- CN
- China
- Prior art keywords
- acid
- indoles
- compound
- reaction
- benzyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Description
实施例 | COX-1 | COX-2 | ||||
浓度 | 30μM | 10μM | 3μM | 300nM | 100nM | 30nM |
SC-58635(标准物) | 81.3 | 66.5 | 64.3 | 73.0 | 59.9 | 51.2 |
1 | 45.8 | 40.7 | 33.2 | ~0 | ~O | ~0 |
2 | 80.4 | 68.7 | 56.7 | 22.0 | 20.7 | 15.7 |
3 | 74.6 | 64.4 | 60.4 | 70.2 | 58.8 | 50.1 |
4 | 80.1 | 71.1 | 60.3 | 81.5 | 69.9 | 55.4 |
5 | 54.3 | 47.1 | 39.9 | 61.4 | 55.4 | 51.2 |
6 | 64.8 | 57.3 | 52.3 | 54.9 | 46.6 | 33.4 |
7 | 56.4 | 44.1 | 30.0 | 76.8 | 70.6 | 59.8 |
8 | 53.9 | 32.3 | 7.6 | 29.6 | 28.6 | 22.1 |
9 | 42.1 | 31.1 | 22.8 | 30.1 | 25.5 | 20.4 |
Claims (3)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20010062492 | 2001-10-10 | ||
KR1020010062492A KR100810468B1 (ko) | 2001-10-10 | 2001-10-10 | 사이클로옥시게나제-2의 저해제로서 선택성이 뛰어난1h-인돌 유도체 |
PCT/KR2002/001843 WO2003031409A1 (en) | 2001-10-10 | 2002-10-02 | 1h-indole derivatives as a highly selective cyclooxygenase-2 inhibitor |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1568311A CN1568311A (zh) | 2005-01-19 |
CN1290832C true CN1290832C (zh) | 2006-12-20 |
Family
ID=19715014
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB028200799A Expired - Fee Related CN1290832C (zh) | 2001-10-10 | 2002-10-02 | 作为高选择性的环加氧酶-2抑制剂的1h-吲哚衍生物 |
Country Status (8)
Country | Link |
---|---|
US (1) | US6599929B2 (zh) |
EP (1) | EP1442016B1 (zh) |
JP (1) | JP4192268B2 (zh) |
KR (1) | KR100810468B1 (zh) |
CN (1) | CN1290832C (zh) |
AT (1) | ATE465146T1 (zh) |
DE (1) | DE60236102D1 (zh) |
WO (1) | WO2003031409A1 (zh) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI224101B (en) | 2001-06-20 | 2004-11-21 | Wyeth Corp | Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
WO2003000253A1 (en) | 2001-06-20 | 2003-01-03 | Wyeth | Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
US7291639B2 (en) | 2001-06-20 | 2007-11-06 | Wyeth | Aryloxy-acetic acid compounds useful as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
KR100804827B1 (ko) * | 2002-05-17 | 2008-02-20 | 씨제이제일제당 (주) | 티아졸리딘-4-온 유도체, 그 제조방법 및 약제학적 조성물 |
US20040147581A1 (en) * | 2002-11-18 | 2004-07-29 | Pharmacia Corporation | Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy |
CN1726190A (zh) | 2002-12-10 | 2006-01-25 | 惠氏公司 | 作为纤溶酶原激活物抑制剂-1(pai-1)的抑制剂的取代3-羰基-1h-吲哚-1-基乙酸衍生物 |
WO2004052853A2 (en) | 2002-12-10 | 2004-06-24 | Wyeth | Substituted 3-alkyl and 3-arylalkyl 1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
MXPA05006287A (es) | 2002-12-10 | 2005-09-08 | Wyeth Corp | Derivados de acido indoloxo-acetilaminoacetico sustituidos como inhibidores del inhibidor del activador de plasminogeno 1 (pai-1). |
CA2509191A1 (en) | 2002-12-10 | 2004-06-24 | Wyeth | Aryl, aryloxy, and alkyloxy substituted 1h-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
UA80453C2 (en) | 2002-12-10 | 2007-09-25 | Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1) | |
US20040220155A1 (en) * | 2003-03-28 | 2004-11-04 | Pharmacia Corporation | Method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith |
EP1631546A1 (en) * | 2003-04-25 | 2006-03-08 | H. Lundbeck A/S | Sustituted indoline and indole derivatives |
WO2005009342A2 (en) * | 2003-07-16 | 2005-02-03 | Pharmacia Corporation | Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith |
US20050119262A1 (en) * | 2003-08-21 | 2005-06-02 | Pharmacia Corporation | Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent |
US20050107350A1 (en) * | 2003-08-22 | 2005-05-19 | Pharmacia Corporation | Method for the treatment or prevention of bone disorders with a cyclooxygenase-2 inhibitor alone and in combination with a bone disorder treatment agent and compositions therewith |
US20050187278A1 (en) * | 2003-08-28 | 2005-08-25 | Pharmacia Corporation | Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors |
WO2005023189A2 (en) * | 2003-09-03 | 2005-03-17 | Pharmacia Corporation | Method of cox-2 selective inhibitor and nitric oxide-donating agent |
US7351726B2 (en) * | 2003-09-25 | 2008-04-01 | Wyeth | Substituted oxadiazolidinediones |
US7420083B2 (en) * | 2003-09-25 | 2008-09-02 | Wyeth | Substituted aryloximes |
US7265148B2 (en) * | 2003-09-25 | 2007-09-04 | Wyeth | Substituted pyrrole-indoles |
US7268159B2 (en) * | 2003-09-25 | 2007-09-11 | Wyeth | Substituted indoles |
US7411083B2 (en) | 2003-09-25 | 2008-08-12 | Wyeth | Substituted acetic acid derivatives |
US7446201B2 (en) * | 2003-09-25 | 2008-11-04 | Wyeth | Substituted heteroaryl benzofuran acids |
US7442805B2 (en) * | 2003-09-25 | 2008-10-28 | Wyeth | Substituted sulfonamide-indoles |
US7534894B2 (en) * | 2003-09-25 | 2009-05-19 | Wyeth | Biphenyloxy-acids |
US7141592B2 (en) * | 2003-09-25 | 2006-11-28 | Wyeth | Substituted oxadiazolidinediones |
US7163954B2 (en) * | 2003-09-25 | 2007-01-16 | Wyeth | Substituted naphthyl benzothiophene acids |
US7582773B2 (en) * | 2003-09-25 | 2009-09-01 | Wyeth | Substituted phenyl indoles |
US7332521B2 (en) * | 2003-09-25 | 2008-02-19 | Wyeth | Substituted indoles |
US7342039B2 (en) * | 2003-09-25 | 2008-03-11 | Wyeth | Substituted indole oximes |
CN101044127A (zh) * | 2004-08-23 | 2007-09-26 | 惠氏公司 | 用作纤溶酶原激活剂抑制剂-1的噻唑基-萘基酸 |
RU2007106868A (ru) | 2004-08-23 | 2008-09-27 | Вайет (Us) | Оксазол-нафтиловые кислоты и их применение в качестве модуляторов ингибитора активатора плазминогена-1 (pai) для лечения тромбоза и сердечно-сосудистых заболеваний |
BRPI0514549A (pt) * | 2004-08-23 | 2008-06-17 | Wyeth Corp | ácidos de pirrol-naftila como inibidores de pai-1 |
EP1919866A2 (en) * | 2005-08-17 | 2008-05-14 | Wyeth a Corporation of the State of Delaware | Substituted indoles and use thereof |
CN102526030A (zh) * | 2010-12-07 | 2012-07-04 | 南京大学 | 3,3`-二吲哚甲烷在炎症性肠病治疗中的应用 |
CN114105854A (zh) * | 2021-10-12 | 2022-03-01 | 宁波天泽新材料科技有限公司 | 一种5-氨基吲哚啉硫酸盐的合成方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE45427B1 (en) * | 1976-07-09 | 1982-08-25 | American Home Prod | Pyrrold 3,2if quinazoline-1,3-diamine and related compounds |
US5474995A (en) | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
GB9514265D0 (en) * | 1995-07-13 | 1995-09-13 | Wellcome Found | Hetrocyclic compounds |
WO1997030030A1 (fr) * | 1996-02-13 | 1997-08-21 | Chugai Seiyaku Kabushiki Kaisha | Derives d'indole |
GB2345486A (en) * | 1999-01-11 | 2000-07-12 | Glaxo Group Ltd | Heteroaromatic protein tyrosine kinase inhibitors |
-
2001
- 2001-10-10 KR KR1020010062492A patent/KR100810468B1/ko not_active IP Right Cessation
-
2002
- 2002-10-02 WO PCT/KR2002/001843 patent/WO2003031409A1/en active Application Filing
- 2002-10-02 DE DE60236102T patent/DE60236102D1/de not_active Expired - Lifetime
- 2002-10-02 AT AT02781902T patent/ATE465146T1/de not_active IP Right Cessation
- 2002-10-02 JP JP2003534393A patent/JP4192268B2/ja not_active Expired - Fee Related
- 2002-10-02 EP EP02781902A patent/EP1442016B1/en not_active Expired - Lifetime
- 2002-10-02 CN CNB028200799A patent/CN1290832C/zh not_active Expired - Fee Related
- 2002-10-03 US US10/264,114 patent/US6599929B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2005508948A (ja) | 2005-04-07 |
US6599929B2 (en) | 2003-07-29 |
CN1568311A (zh) | 2005-01-19 |
EP1442016A4 (en) | 2005-05-25 |
ATE465146T1 (de) | 2010-05-15 |
EP1442016B1 (en) | 2010-04-21 |
EP1442016A1 (en) | 2004-08-04 |
KR100810468B1 (ko) | 2008-03-07 |
DE60236102D1 (en) | 2010-06-02 |
KR20030030382A (ko) | 2003-04-18 |
US20030109568A1 (en) | 2003-06-12 |
WO2003031409A1 (en) | 2003-04-17 |
JP4192268B2 (ja) | 2008-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1290832C (zh) | 作为高选择性的环加氧酶-2抑制剂的1h-吲哚衍生物 | |
CN1133627C (zh) | N-苄基二氧代噻唑烷基苯甲酰胺衍生物的制造中间体及其制造方法 | |
CN1181825C (zh) | 秋水仙醇衍生物在制备作为血管破坏剂的药物中的应用 | |
CN1216047C (zh) | 三环内酰胺和磺内酰胺衍生物和它们作为组蛋白脱乙酰基转移酶抑制剂的应用 | |
CN1213046C (zh) | 四氢吡啶衍生物,它们的制备和它们作为细胞增殖抑制剂的应用 | |
CN1476424A (zh) | 萘衍生物 | |
CN1829728A (zh) | 新颖化合物 | |
CN101058549A (zh) | 4-甲氧基-1,3-苯二取代酰胺衍生物 | |
CN1399633A (zh) | 嘧啶衍生物 | |
CN1966506A (zh) | 吡唑并嘧啶酮衍生物及其制备方法和用途 | |
CN1202106A (zh) | 选择性的β3肾上腺素能激动剂 | |
CN1245382C (zh) | 作为高选择性的环加氧酶-2抑制剂的4'-甲磺酰基联苯衍生物 | |
CN1147485C (zh) | 用作5-ht-2c受体拮抗剂的二氢吲哚衍生物 | |
CN1094930C (zh) | 喹喔啉及其制备方法与应用 | |
CN1882564A (zh) | 调节类香草素-1受体(vr1)功能的吲唑-3-酮及其类似物和衍生物 | |
CN1166623C (zh) | 2-苯氧基苯胺类衍生物 | |
CN1255387C (zh) | 可用作选择性cox-2抑制剂的嘧啶衍生物 | |
CN1025857C (zh) | 制备具有药理性质的噻唑并[5,4-b][1,5]苯并二氮杂的方法 | |
CN1127482C (zh) | 含有磺酰基二苯基吲哚化合物及其制法和药物用途 | |
CN1849117A (zh) | Hiv病毒的侵入抑制剂 | |
CN1239478C (zh) | 作为环加氧酶-2的高选择性抑制剂的3,4-二氢-1h-萘类衍生物 | |
CN1290842C (zh) | 用作高选择性环加氧酶-2抑制剂的二芳基1,2,4-三唑衍生物 | |
CN1041938A (zh) | 3-酰基-2-氧代吲哚-1-羟酰胺抗炎剂的前药 | |
CN1056369C (zh) | 哒嗪酮衍生物或其盐和制备方法 | |
CN1065454A (zh) | 旋光活性羧酸及其制法和药用组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: CJ CHEIL JEDANG CORP. Free format text: FORMER OWNER: CHEIL JEDANG CORP. Effective date: 20080912 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20080912 Address after: Seoul, South Kerean Patentee after: CJ Corp. Address before: Seoul, South Kerean Patentee before: First sugar refining Corporation |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20061220 Termination date: 20151002 |
|
EXPY | Termination of patent right or utility model |